Q1 2025 Medifast Inc Earnings Call Transcript
Key Points
- Medifast Inc (MED) reported that revenues and EPS were within guidance range for the first quarter of 2025.
- The company saw a meaningful year-over-year increase in new coaches for the first time in three years, with a double-digit increase compared to the same period last year.
- Medifast Inc (MED) is focusing on empowering coaches by streamlining the coach development path and enhancing tools and insights available to them.
- The OPTAVIA program is designed to support long-term health goals, offering a holistic approach with science-backed products and personalized nutrition plans.
- The company maintains a strong balance sheet with $164.6 million in cash and no interest-bearing debt as of March 31, 2025.
- Revenue for the first quarter decreased by 33.8% compared to the previous year, primarily due to a decrease in the number of active earning OPTAVIA coaches.
- The number of active earning OPTAVIA coaches decreased by 32.8% from the first quarter of 2024.
- SG&A expenses as a percentage of revenue increased by 560 basis points due to lower sales volumes and company-led marketing efforts.
- Medifast Inc (MED) reported a net loss of $0.8 million in the first quarter of 2025, compared to a net income of $8.3 million in the same period last year.
- The company anticipates potential consumer demand headwinds due to a weaker economy, which could impact future performance.
Greetings, and welcome to the Medifast first quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Steven Zenker, Vice President, Investor Relations. Steven, please go ahead.
Good afternoon, and welcome to Medifast's first quarter 2025 earnings conference call. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer. By now, everyone should have access to the earnings release for the first quarter ended March 31, 2025, that went out this afternoon at approximately 4:05 PM Eastern Time.
If you have not received the release, it is available on the Investor Relations portion of Medifast's website at www.medifastinc.com. This call is being webcast, and a replay will also be available on the company's website.
Before we begin, we would like to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
